ReviewInvestigative ophthalmology & visual science2025
IMI-Instrumentation for Myopia Management.
Review in Investigative ophthalmology & visual science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
15 citing papers in PubMed.
- Defocus incorporated multiple segment spectacle lenses versus orthokeratology lenses for myopia control: a non-inferiority randomised clinical trial.BMC ophthalmology · 2026Trial
- Cost-Effectiveness Analysis of Low-Dose Atropine Eye Drops (0.01%) for the Treatment of Myopia in Children: A United Kingdom Perspective.PharmacoEconomics · 2026Article
- Detection of Myopia from Colour Fundus Photographs Using YOLO-Based Computer-Vision Models: A Comparison with Expert Ophthalmologists.Journal of clinical medicine · 2026Article
- Shared Genetic Architecture and Multidimensional Modifiable Correlates between Myopia and Retinal-Optic Nerve Diseases.Ophthalmology science · 2026Article
- Beyond Screen Time: A Measurement Framework for Behavioral Exposures in Childhood Myopia.Life (Basel, Switzerland) · 2026Review
- Short-Term Changes in Retinal Activity With Four Myopia Control Spectacle Lenses.Translational vision science & technology · 2026Article
- Clinical Comparative Evaluation of Two New-Generation Optical Biometers: Intrasession Repeatability and Agreement of Biometric Parameters.Diagnostics (Basel, Switzerland) · 2026Article
- Identifying and Managing Pre-Myopia: A Narrative Review.Clinical ophthalmology (Auckland, N.Z.) · 2026Review
- Associated factors of myopia in a Portuguese sample of adolescents: Parental history and school-related lifestyle.PloS one · 2026Article
- Centile curves of refraction in children and adolescents aged 5-18 in Hubei Province: a study based on GAMLSS to predict refraction development.International journal of ophthalmology · 2026Article
- Establishing and validating a predictive model for long-term control outcomes following orthokeratology lenses wear: a five-year cohort study.Frontiers in cell and developmental biology · 2026Article
- Predicting myopia risk using a machine learning model based on fundus imageomics.Scientific reports · 2025Article
- IMI-Interventions for Controlling Myopia Onset and Progression 2025.Investigative ophthalmology & visual science · 2025Review
- Diagnostic challenges in high myopia: identification of sight-threatening complications and the role of artificial intelligence.Frontiers in ophthalmology · 2025Review
- Scoping Review of the Role of Accommodation and Binocular Coordination in Myopia Onset and Progression.Clinical ophthalmology (Auckland, N.Z.) · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The rising prevalence of myopia has underscored the importance of early diagnosis and effective management strategies to control its progression and to prevent complications. Advancements in instrumentation enable clinicians to provide individualized evidence-based care for patients. Instrumentation for myopia control encompasses a wide range of technologies designed to assess refractive error, biometric parameters, including axial length, accommodative responses, as well as detailed assessment of ocular health. These tools offer clinicians the ability to move beyond traditional clinical techniques, providing more accurate, detailed, and repeatable measurements critical for the detection and monitoring of myopia progression. This allows for a personalized approach to treatment planning, enabling the selection and optimization of myopia control interventions. Furthermore, advanced imaging and real-time data visualization support patient education by fostering understanding, which may improve adherence to treatment plans. By adopting these technologies, clinicians can address the complexities of myopia management, deliver precise and effective care, and contribute to global efforts to curb the myopia epidemic. The integration of advanced instrumentation into clinical practice encourages early intervention and management strategies for patients at risk of becoming myopic (pre-myopia), as well as improving patient outcomes for myopic patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.